Fatalities linked to Covid-19 have been decreasing worldwide, even though the number of cases has been rocketing again since people have returned from holiday. But this may also be because so many more tests are being carried out. Quite simply, more infections may simply be the result of more swabs.

As the search for a Covid-19 vaccine continues frantically, AstraZeneca last week dampened hopes of a quick fix, halting clinical trials after a potentially unexplained disease surfaced. This should be a reminder that vaccine discovery is a long, painstaking process. Happily, the group announced over the weekend that the trials had resumed.

Economies continue to recover slowly. In the US, initial jobless claims have levelled off at a high rate, with unemployment at 8.4%. The services sector slowed in August, as illustrated by a non-manufacturing ISM index falling from 58.1 to 56.9 last month. New stimulus measures are expected, although Republicans and Democrats are disagreeing on which form this should take.

In Europe, the euro’s strength is triggering serious debate. The currency has appreciated 10% against the US dollar since March. Leading up to the ECB meeting, the latest economic stats showed a regional economy running out of steam. Yet Christine Lagarde was last week strangely optimistic about the bloc’s prospects. There was talk about the euro’s high value within the governing council, but her remarks betrayed no sense of urgency, even though a strong currency is deflationary and undermines competitiveness. In reality, the optimism seems to be tied to the level of stock markets.

Volatility ticked up in financial markets last week in the wake of the Nasdaq correction and the slide by US tech darlings, which seemed unstoppable. The magnitude of these swings was disconcerting, bearing in mind that the 15% correction in Apple’s share price represented drawdown of around USD 300 billion – the equivalent of Nestlé’s market capitalisation.

The uptick in volatility seems to be magnified by a new phenomenon: options-based speculation by retail investors. The leverage provided by these instruments is huge. Over the past four weeks, retail traders (using applications such as Robinhood) have spent around USD 37 billion on call options, giving them notional exposure of more than USD 300 billion. These readily available instruments started to become popular during lockdown when many gamblers withdrew to the stock market, which ever since has been on a non-stop winning streak.
If you have any questions please contact the office on (03) 9670 6070.